Femara 2.5 mg
Femara 2.5 mg is a medicine authorised by Swissmedic under authorisation number 54018. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 February 1997 and the authorisation is valid without a time limit. ATC code L02BG04 places the medicine in the group Endocrine therapy.
| Authorisation number | 54018 |
|---|---|
| Name | Femara 2.5 mg |
| Full name | Femara 2.5 mg, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BG04 |
| First authorisation | 26 February 1997 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Femara 2.5 mg, Filmtabletten | B | 21 September 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | L02BG04 | 07.16.2. | B |
| 2 | 100 | Tablette(n) | L02BG04 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Femara 2.5 mg authorised in Switzerland?
Yes. Femara 2.5 mg is authorised by Swissmedic under authorisation number 54018, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Femara 2.5 mg have?
Femara 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Femara 2.5 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.